Revolution Medicines, Inc. (RVMDW) Net margin 2018–2023
Revolution Medicines, Inc. (RVMDW) net profit margin by fiscal year — reported net income divided by reported revenue.
-3768.3%FY2023 · since FY2018: -207.2% → -3768.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -3768.3% | -3065.3 pp |
| FY2022 | -703.0% | -66.4 pp |
| FY2021 | -636.6% | -384.9 pp |
| FY2020 | -251.6% | -156.4 pp |
| FY2019 | -95.2% | +112.0 pp |
| FY2018 | -207.2% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice